Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127066101 | 12706610 | 1 | I | 20160801 | 20160901 | 20160901 | EXP | ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122638 | RANBAXY | BLANCA-LOPEZ N, PEREZ-ALZATE D, ANDREU I, DONA I, AGUNDEZ JA, GARCIA-MARTIN E, ET AL. IMMEDIATE HYPERSENSITIVITY REACTIONS TO IBUPROFEN AND OTHER ARYLPROPIONIC ACID DERIVATIVES. ALLERGY. 2016;71(7):1048-1056 | 36.00 | YR | F | Y | 0.00000 | 20160901 | OT | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127066101 | 12706610 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | U | U | 71214 | ||||||||
127066101 | 12706610 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | UNK | U | U | 0 | ||||||||
127066101 | 12706610 | 3 | SS | Diclofenac | DICLOFENAC | 1 | Oral | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127066101 | 12706610 | 1 | Product used for unknown indication |
127066101 | 12706610 | 2 | Product used for unknown indication |
127066101 | 12706610 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127066101 | 12706610 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127066101 | 12706610 | Anaphylactic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |